Cargando…

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva

Mostrar otras versiones (1)

The approved Pfizer and Moderna mRNA vaccines are well known to induce serum antibody responses to the SARS-CoV-2 Spike (S)-protein. However, their abilities to elicit mucosal immune responses have not been reported. Saliva antibodies represent mucosal responses that may be relevant to how mRNA vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ketas, Thomas J., Chaturbhuj, Devidas, Portillo, Victor M Cruz, Francomano, Erik, Golden, Encouse, Chandrasekhar, Sharanya, Debnath, Gargi, Díaz-Tapia, Randy, Yasmeen, Anila, Kramer, Kyle D., Munawar, Tarek, Leconet, Wilhelm, Zhao, Zhen, Brouwer, Philip J.M., Cushing, Melissa M., Sanders, Rogier W., Cupo, Albert, Klasse, Per Johan, Formenti, Silvia C., Moore, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201795/ https://www.ncbi.nlm.nih.gov/pubmed/34136730 http://dx.doi.org/10.20411/pai.v6i1.441

Ejemplares similares

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells
por: Cupo, Albert, et al.
Publicado: (2019)

Is tumor (R)ejection by the immune system the “5th R” of radiobiology?
por: Golden, Encouse B, et al.
Publicado: (2014)

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
por: Chung, Nancy PY, et al.
Publicado: (2014)

Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin
por: Ringe, Rajesh P., et al.
Publicado: (2020)

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate
por: Dey, Antu K., et al.
Publicado: (2017)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
por: Colin, Philippe, et al.
Publicado: (2023)

Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
por: Colin, Philippe, et al.
Publicado: (2023)

Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers
por: Ringe, Rajesh P., et al.
Publicado: (2017)

Record of Tests of Saliva
por: Cushing, Geo. H.
Publicado: (1874)

The convergence of radiation and immunogenic cell death signaling pathways
por: Golden, Encouse B., et al.
Publicado: (2012)

PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain
por: Chaturbhuj, Devidas, et al.
Publicado: (2018)

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
por: Sanders, Rogier W., et al.
Publicado: (2013)

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
por: Klasse, P. J., et al.
Publicado: (2018)

Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
por: Golden, Encouse B, et al.
Publicado: (2014)

Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro
por: Ozorowski, Gabriel, et al.
Publicado: (2018)

Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
por: Antanasijevic, Aleksandar, et al.
Publicado: (2020)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
por: Ringe, Rajesh P., et al.
Publicado: (2023)

MRI-LINAC: A transformative technology in radiation oncology
por: Ng, John, et al.
Publicado: (2023)

Evaluation of a Cost Effective In-House Method for HIV-1 Drug Resistance Genotyping Using Plasma Samples
por: Chaturbhuj, Devidas N., et al.
Publicado: (2014)

Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health
por: Racine-Brzostek, Sabrina E, et al.
Publicado: (2021)

Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
por: Derking, Ronald, et al.
Publicado: (2015)

Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
por: Racine-Brzostek, Sabrina E., et al.
Publicado: (2021)

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
por: Klasse, P. J., et al.
Publicado: (2016)

Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
por: Derking, Ronald, et al.
Publicado: (2021)

Saliva sample and SARS-CoV-2 detection: More complexities than clarity
por: Sarode, Sachin C., et al.
Publicado: (2021)

Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia
por: Sugita, Mayumi, et al.
Publicado: (2023)

Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation
por: Patil, Rajesh T., et al.
Publicado: (2014)

Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
por: Yang, He S., et al.
Publicado: (2021)

Quantification of betel quid hygroscopicity in context to saliva: A proof of concept for future studies
por: Sarode, Sachin C., et al.
Publicado: (2023)

Alkaline Saliva
por: Fletcher, M. H.
Publicado: (1900)

SaliVISION: a rapid saliva-based COVID-19 screening and diagnostic test with high sensitivity and specificity
por: DeFina, Samuel M., et al.
Publicado: (2022)

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
por: Brouwer, Philip J. M., et al.
Publicado: (2021)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2017)

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2023)

Erosion protection conferred by whole human saliva, dialysed saliva, and artificial saliva
por: Baumann, T., et al.
Publicado: (2016)

Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
por: Brouwer, Philip J. M., et al.
Publicado: (2019)

Saliva
por: Cutler, Andrew S.
Publicado: (1868)

Saliva
por: Vaughn, C.
Publicado: (1887)

Cannot write session to /tmp/vufind_sessions/sess_fk0sqd50nb27pmoi96cuqpeofm